Literature DB >> 30685785

An epidemiologic study of pelvic organ prolapse in rural Chinese women: a population-based sample in China.

Zhiyi Li1, Tao Xu2, Zhaoai Li3, Jian Gong4, Qing Liu5, Lan Zhu6.   

Abstract

INTRODUCTION AND HYPOTHESIS: We aimed to investigate the prevalence and risk factors of symptomatic pelvic organ prolapse (POP) in rural China.
METHODS: A cross-sectional study of POP was conducted in rural China from February 2014 to March 2016. In total, 25,864 rural women were recruited. All were asked to complete a questionnaire that included questions about their age, job, parity, diseases, and so on. Symptomatic POP was assessed using Pelvic Organ Prolapse Quantification (POP-Q) system staging and validation questionnaires. Multivariate logistic regression was used to assess the factors associated with symptomatic POP.
RESULTS: The prevalence of symptomatic POP was 9.10%. There was a consistent trend toward an increasing prevalence of POP with increasing age, ranging from 2.53 to 13.40% (P < 0.0001). Women aged 50-59 years [adjusted odds ratio (AOR) 1.86, 95% confidence interval (CI) 1.46-2.37] were more likely to have POP than women aged 20-29 years. POP was positively associated with giving birth to more than three children (AOR 2.18, 95% CI 1.88-2.43). Cesarean section was a significant protective factor (AOR = 0.34, 95% CI 0.33-0.49) compared with vaginal delivery. Multivariate logistic regression analysis showed that obesity, constipation, smoking, coughing, gynecological diseases, and other physical diseases were also associated with POP.
CONCLUSIONS: Symptomatic POP affects a substantial proportion of women in rural China. Older age, multiparity, vaginal delivery, obesity, and many chronic conditions significantly increased the odds of developing symptomatic POP. Additional healthcare campaigns are needed to educate women in rural areas about POP.

Entities:  

Keywords:  Epidemiology; Pelvic organ prolapse; Prevalence; Risk factors; Rural

Mesh:

Year:  2019        PMID: 30685785     DOI: 10.1007/s00192-018-03859-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  7 in total

1.  One in ten ever-married women who visited health facilities for various reasons have pelvic organ prolapse in Harari regional state, Eastern Ethiopia.

Authors:  Dawit Abebe; Mohammed Abdurke Kure; Enku Afework Demssie; Sinetibeb Mesfin; Melake Demena; Merga Dheresa
Journal:  BMC Womens Health       Date:  2022-06-11       Impact factor: 2.742

2.  Pelvic Floor Considerations in COVID-19.

Authors:  Carina Siracusa; Amelia Gray
Journal:  J Womens Health Phys Therap       Date:  2020-10-14

3.  Factors associated with delay in seeking treatment among women with pelvic organ prolapse at selected general and referral hospitals of Southern Ethiopia, 2020.

Authors:  Asfaw Borsamo; Mohammed Oumer; Yared Asmare; Ayanaw Worku
Journal:  BMC Womens Health       Date:  2021-03-01       Impact factor: 2.809

4.  Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse: A Single Center Experience in China.

Authors:  Ke Niu; Qingzhi Zhai; Wensheng Fan; Li'an Li; Wen Yang; Mingxia Ye; Yuanguang Meng
Journal:  J Healthc Eng       Date:  2022-01-12       Impact factor: 2.682

5.  Pelvic organ prolapse and associated factors among women admitted to gynecology ward at the Hiwot Fana Comprehensive Specialized Hospital, Harar, eastern Ethiopia.

Authors:  Abdek Ali; Elias Yadeta; Addis Eyeberu; Lemesa Abdisa; Miressa Bekana; Merga Dheresa
Journal:  SAGE Open Med       Date:  2022-09-22

6.  Mesenchymal stem cell transplantation for vaginal repair in an ovariectomized rhesus macaque model.

Authors:  Ye Zhang; Yidi Ma; Juan Chen; Min Wang; Yuan Cao; Lei Li; Hua Yang; Xudong Liu; Yaqian Li; Lan Zhu
Journal:  Stem Cell Res Ther       Date:  2021-07-15       Impact factor: 6.832

Review 7.  Age and/or postmenopausal status as risk factors for pelvic organ prolapse development: systematic review with meta-analysis.

Authors:  Luiz Gustavo Oliveira Brito; Glaucia Miranda Varella Pereira; Pamela Moalli; Oksana Shynlova; Jittima Manonai; Adi Yehuda Weintraub; Jan Deprest; Maria Augusta T Bortolini
Journal:  Int Urogynecol J       Date:  2021-08-05       Impact factor: 1.932

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.